Rice Hall James & Associates
$2.1B 13F equity value
255 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Rice Hall James & Associates covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | 270,052 | $85M | 4.2% |
| ACIW | ACI WORLDWIDE INC | 1,006,595 | $51M | 2.5% |
| ARLO | ARLO TECHNOLOGIES INC | 3,732,962 | $50M | 2.4% |
| FN | FABRINET | 87,577 | $49M | 2.4% |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 560,935 | $48M | 2.3% |
| XPO | XPO INC | 224,878 | $46M | 2.2% |
| ZD | ZIFF DAVIS INC | 821,496 | $43M | 2.1% |
| FOUR | SHIFT4 PMTS INC | 874,492 | $43M | 2.1% |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 624,928 | $40M | 1.9% |
| ASND | ASCENDIS PHARMA A/S | 148,644 | $40M | 1.9% |
Track Rice Hall James & Associates's 13F portfolio: $2.1B in reported holdings, 255 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}